Chemocentryx Stock Performance

CCXI
 Stock
  

USD 51.82  0.16  0.31%   

Chemocentryx holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.1818, which signifies not very significant fluctuations relative to the market. Let's try to break down what Chemocentryx's beta means in this case. As returns on the market increase, Chemocentryx returns are expected to increase less than the market. However, during the bear market, the loss on holding Chemocentryx will be expected to be smaller as well. Although it is essential to pay attention to Chemocentryx historical returns, it is also good to be reasonable about what you can do with equity current trending patterns. Our philosophy in foreseeing future performance of any stock is to look not only at its past charts but also at the business as a whole, including all fundamental and technical indicators. To evaluate if Chemocentryx expected return of 1.72 will be sustainable into the future, we have found twenty-seven different technical indicators, which can help you to check if the expected returns are sustainable. Use Chemocentryx maximum drawdown, and the relationship between the information ratio and expected short fall to analyze future returns on Chemocentryx.
  
Chemocentryx Performance
9 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Chemocentryx are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Chemocentryx reported solid returns over the last few months and may actually be approaching a breakup point. ...more

Chemocentryx Price Channel

Quick Ratio4.99
Fifty Two Week Low14.95
Target High Price106.00
Fifty Two Week High51.85
Target Low Price52.00

Chemocentryx Relative Risk vs. Return Landscape

If you would invest  2,533  in Chemocentryx on July 6, 2022 and sell it today you would earn a total of  2,649  from holding Chemocentryx or generate 104.58% return on investment over 90 days. Chemocentryx is currently generating 1.7152% in daily expected returns and assumes 13.884% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Chemocentryx, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Chemocentryx is expected to generate 11.52 times more return on investment than the market. However, the company is 11.52 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The DOW is currently generating roughly -0.06 per unit of risk.

Chemocentryx Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Chemocentryx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chemocentryx, and traders can use it to determine the average amount a Chemocentryx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1235

Best
Portfolio
Best
Equity
Good Returns
Average ReturnsCCXI
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 13.88
  actual daily
 
 96 %
of total potential
 
9696
Expected Return
 1.72
  actual daily
 
 33 %
of total potential
 
3333
Risk-Adjusted Return
 0.12
  actual daily
 
 9 %
of total potential
 
99
Based on monthly moving average Chemocentryx is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chemocentryx by adding it to a well-diversified portfolio.

About Chemocentryx Performance

To evaluate Chemocentryx Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Chemocentryx generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Chemocentryx Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Chemocentryx market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Chemocentryx's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 178 people.

Things to note about Chemocentryx

Checking the ongoing alerts about Chemocentryx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chemocentryx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Chemocentryx Alerts

Equity Alerts and Improvement Suggestions

Chemocentryx is way too risky over 90 days horizon
Chemocentryx appears to be risky and price may revert if volatility continues
Chemocentryx is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 27.33 M. Net Loss for the year was (140.65 M) with loss before overhead, payroll, taxes, and interest of (51.07 M).
Chemocentryx currently holds about 340.6 M in cash with (45.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.78.
Over 80.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.gurufocus.com: Amgen CEO Sees Tougher Sleddin - GuruFocus.com
Continue to Trending Equities. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Chemocentryx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemocentryx. If investors know Chemocentryx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemocentryx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.